[Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents].
D V
DV
Preobrazhenskiĭ
D023903:Coronary Restenosis / Q000453:epidemiology / Q000517:prevention & control*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D054855:Drug-Eluting Stents; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D012189:Retrospective Studies; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology; D015996:Survival Rate; D013997:Time Factors; D028761:Withholding Treatment
D010975:Platelet Aggregation Inhibitors